Karin R. Aubrey
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects.
Journal: bioRxiv : the preprint server for biology
Published: December 03, 2025
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects.
Journal: Nature communications
Published: June 03, 2025
Catalysing change in health and medical research policy: an Australian case study of deliberative democracy to reform sex and gender policy recommendations.
Journal: Frontiers in public health
Published: November 04, 2024
Supraspinal glycinergic neurotransmission in pain: A scoping review of current literature.
Journal: Journal of neurochemistry
Published: February 07, 2024
Cannabis constituents for chronic neuropathic pain; reconciling the clinical and animal evidence.
Journal: Journal of neurochemistry
Published: May 31, 2023
Bidirectional Modulation of Nociception by GlyT2+ Neurons in the Ventrolateral Periaqueductal Gray.
Journal: eNeuro
Published: February 28, 2023
Spinal glycinergic currents are reduced in a rat model of neuropathic pain following partial nerve ligation but not chronic constriction injury.
Journal: Journal of neurophysiology
Published: December 21, 2022
Kappa opioids inhibit the GABA/glycine terminals of rostral ventromedial medulla projections in the superficial dorsal horn of the spinal cord.
Journal: The Journal of physiology
Published: February 24, 2022
Pharmacologic Management of Persistent Pain in Cancer Survivors.
Journal: Drugs
Published: January 10, 2022
Transition from acute to chronic pain: where cells, systems and society meet.
Journal: Pain management
Published: October 28, 2020
Transition from acute to chronic pain after surgery.
Journal: Lancet (London, England)
Published: August 13, 2018
Last Updated: 09/26/2026